Evidence map›Paper›PMID 33216274›Full record

ArticleMedicine, health care, and philosophy2021

Optimizing peer review to minimize the risk of retracting COVID-19-related literature.

Jaime A Teixeira da Silva, Helmar Bornemann-Cimenti, Panagiotis Tsigaris

Abstract read
In one paragraph

Article in Medicine, health care, and philosophy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jaime A Teixeira da SilvaIndependent Researcher, Miki-cho, Japan. jaimetex@yahoo.com.
Helmar Bornemann-CimentiDepartment of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria. helmar.bornemann@medunigraz.at.
Panagiotis TsigarisDepartment of Economics, Thompson Rivers University, 805 TRU Way, Kamloops, BC, V2C 0C8, Canada. ptsigaris@tru.ca.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Retractions of COVID-19 literature in both preprints and the peer-reviewed literature serve as a reminder that there are still challenging issues underlying the integrity of the biomedical literature. The risks to academia become larger when such retractions take place in high-ranking biomedical journals. In some cases, retractions result from unreliable or nonexistent data, an issue that could easily be avoided by having open data policies, but there have also been retractions due to oversight in peer review and editorial verification. As COVID-19 continues to affect academics and societies around the world, failures in peer review might also constitute a public health risk. The effectiveness by which COVID-19 literature is corrected, including through retractions, depends on the stringency of measures in place to detect errors and to correct erroneous literature. It also relies on the stringent implementation of open data policies.

Indexed as

Peer ReviewRetraction of Publication as TopicCOVID-19Editorial PoliciesHumansPeriodicals as TopicRisk FactorsTime FactorsAcademic qualityCorrectionPublic health riskRetractionType I and II errorsWithdrawal

Identifiers

PMID33216274
PMCPMC7678589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.